Comparison of concomitant drug confirmation methods in community pharmacies for patients using multiple drugs

Open-label, multicenter, randomized, parallel-group comparative study for the utility of telephone follow-up in community pharmacies for the detection of triple whammy in multiple drug combination patients - Comparison of concomitant drug confirmation methods in community pharmacies for detection of triple whammy in multiple drug combination patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047550

Enrollment

Registered

2022-04-21

Start date

2022-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients prescribed diuretics and renin-angiotensin system inhibitors (angiotensin converting enzyme inhibitors

Interventions

Telephone follow-up Follow-up in community pharmacy at next visit

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who take prescriptions to the study participating pharmacy 2. Patients on a dual combination of a diuretic and ACEI or ARB

Exclusion criteria

Exclusion criteria: 1. Patients who failed to obtain consent to the study 2. Patients or agents unable to respond to telephone calls, such as cognitive decline or hearing loss

Design outcomes

Primary

Measure	Time frame
Number and type of concomitant drugs	—

Secondary

Measure	Time frame
Number of pharmacists consultation to prescribing physician, and renal function	—

Countries

Japan

Contacts

Public ContactSaki Kashikawa

Shiga Pharmaceutical Association Kaiei Pharmacy Pharmacy

kaiei@shigayaku.or.jp077-567-2435

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026